Bone formation following OP-1 implantation is improved by addition of autogenous bone marrow cells in a canine femur defect model

Journal of Orthopaedic Research

Volumn 25, Issue 10, 2007, Pages 1333-1342

  Takigami, Hidetake ^a   Kumagai, Ken ^a   Latson, Larry ^a   Togawa, Daisuke ^a   Bauer, Thomas ^a   Powell, Kimerly ^a   Butler, Robert S ^a   Muschler, George F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bone graft; Bone marrow cells; Connective tissue progenitors; Femur defect; OP 1

Indexed keywords

OSTEOGENIC PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BONE GRAFT; BONE MARROW; BONE MARROW CELL; CONNECTIVE TISSUE; CONTROLLED STUDY; DOG; FEMUR MALFORMATION; FRACTURE HEALING; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; STEM CELL;

ANIMALS; BONE MARROW TRANSPLANTATION; BONE MORPHOGENETIC PROTEINS; DISEASE MODELS, ANIMAL; DOGS; FEMORAL FRACTURES; FEMUR; FRACTURE HEALING; IMPLANTS, EXPERIMENTAL; MALE; OSTEOGENESIS; OSTEOTOMY; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA;

EID: 34948872003     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20411     Document Type: Article

References (36)

1. Bauer TW, Muschler GF. 2000. Bone graft materials. An overview of the basic science. Clin Orthop 371:10-27.
2. Fleming JE Jr, Cornell CN, Muschler GF. 2000. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am 31:357-374.
3. Khan SN, Bostrom MP, Lane JM. 2000. Bone growth factors. Orthop Clin North Am 31:375-388.
4. Muschler GF, Lane JM. 1999. Spine fusion: principles of bone fusion. In: Herkowitz HN, Garfin SR, Balderston RA, et al., editors. The spine, 4th ed. Philadelphia: WB Saunders; p 1573-1589.
5. Mirovsky Y, Neuwirth MG. 2000. Comparison between the outer table and intracortical methods of obtaining autogenous bone graft from the iliac crest. Spine 25:1722-1725.
6. St John TA, Vaccaro AR, Sah AP, et al. 2003. Physical and monetary costs associated with autogenous bone graft harvesting. Am J Orthop 32:18-23.
7. Weinstein JN, McLain RF. 1987. Primary tumors of the spine. Spine 12:843-851.
8. Younger EM, Chapman MW. 1989. Morbidity at bone graft donor sites. J Orthop Trauma 3:192-195.
9. Urist MR. 1965. Bone: formation by autoinduction. Science 150:893-899.
10. Urist MR, Mikulski A, Lietze A. 1979. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 76:1828-1832.
11. Cook SD, Baffes GC, Wolfe MW, et al. 1994. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg [Am] 76:827-838.
12. Cook SD, Dalton JE, Tan EH, et al. 1994. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 19:1655-1663.
13. Cook SD, Wolfe MW, Salkeld SL, Rueger DC. 1995. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg [Am] 77:734-750.
14. Muschler GF, Nakamoto C, Griffith LG. 2004. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg [Am] 86-A:1541-1558.
15. Muschler GF, Boehm C, Easley K. 1997. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg [Am] 79:1699-1709.
16. Muschler GF, Midura RJ. 2002. Connective tissue progenitors: practical concepts for clinical applications. Clin Orthop 395:66-80.
17. Muschler GF, Midura RJ, Nakamoto C. 2003. Practical modeling concepts for connective tissue stem cell and progenitor compartment kinetics. J Biomed Biotechnol 2003:170-193.
18. Lane JM, Yasko AW, Tomin E, et al. 1999. Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop Relat Res 361:216-227.
19. Noshi T, Yoshikawa T, Ikeuchi M, et al. 2000. Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J Biomed Mater Res 52:621-630.
20. Muschler GF, Matsukura Y, Nitto H, et al. 2005. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop 432:242-251.
21. Muschler GF, Nitto H, Matsukura Y, et al. 2003. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop 407:102-118.
22. Grass M, Kohler T, Proksa R. 2000. 3D cone-beam CT reconstruction for circular trajectories. Phys Med Biol 45:329-347.
23. Yanowitz SD, Bruckstein AM. 1989. A new method for image segmentation. Comput Vision Graph Image Process 46:82-95.
24. Tiedeman JJ, Connolly JF, Strates BS, Lippiello L. 1991. Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. Clin Orthop 268:294-302.
25. Connolly JF. 1998. Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis. Clin Orthop 355 Suppl: S257-S266.
26. Connolly JF, Guse R, Tiedeman J, Dehne R. 1991. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop 266:259-270.
27. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, et al. 2005. Circulating osteoblast-lineage cells in humans. N Engl J Med 352:1959-1966.
28. Wan C, He Q, Li G. 2006. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. J Orthop Res 24:610-618.
29. Kuznetsov SA, Mankani MH, Gronthos S, et al. 2001. Circulating skeletal stem cells. J Cell Biol 153:1133-1140.
30. Gautier E, Perren SM, Cordey J. 2000. Strain distribution in plated and unplated sheep tibia: an in vivo experiment. Injury 31:C37-C44.
31. Uhthoff HK, Foux A, Yeadon A, et al. 1993. Two processes of bone remodeling in plated intact femora: an experimental study in dogs. J Orthop Res 11:78-91.
32. Boden SD, Zdeblick TA, Sandhu HS, et al. 2000. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25:376-381.
33. Burkus JK, Transfeldt EE, Kitchel SH, et al. 2002. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 27:2396-2408.
34. Lanman TH, Hopkins TJ. 2004. Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to poly(L-lactide-co-D,L- lactide) bioresorbable implants. Neurosurg Focus 16:E9.
35. Friedlaender GE, Perry CR, Cole JD, et al. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg [Am] 83-A(Suppl 1):S151-S158.
36. Pierce AR, Piccirilli G, Smith SY, et al. Biodistribution of osteogenic protein-1 (OP-1/BMP-7) following intraosseous implantation of OP-1 putty in a rabbit tibial model. Hopkinton, MA: Stryker Biotech Inc.